Novo CEO pressed by Senate to cut prices of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would look at new talks with insurers about the record costs of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. Earlier this summer https://kethek.com/